Hertab 250 mg Tablet 30N | 30 Tablets in 1 Bottle

Introduction of Hertab 250 mg Tablet 30N

Hertab 250 mg Tablet 30N is an anticancer medication used in the treatment of certain types of cancer. Hertab 250 mg Tablet 30N is primarily used for breast cancer and is used in combination with other cancer medications. Hertab 250 mg Tablet 30N belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the signals that promote cancer cell growth.

Hertab 250 mg Tablet 30N may cause some common side effects including nausea, headache, back pain, and breathing difficulty. It may cause severe diarrhoea, drink plenty of fluids or consult with your doctor if it bothers you. You may be asked to regularly monitor blood pressure while taking this medicine. Inform your doctor if you notice a severe headache, confusion, problems with your eyesight, nausea, or vomiting. Your doctor may check your liver function before, during, and after treatment with this medicine.

Hertab 250 mg Tablet 30N may be used with caution for patients suffering from any liver-related disease hepatotoxicity, In this patients monitoring liver function tests before starting treatment. Discontinue and do not restart Hertab 250 mg Tablet 30N, if patients experience severe changes in liver function tests. Hertab 250 mg Tablet 30N has been associated with Interstitial lung disease and pneumonitis. Discontinue Hertab 250 mg Tablet 30N, if patients experience severe pulmonary symptoms.

Before taking Hertab 250 mg Tablet 30N, let your doctor know if you have liver or kidney problems. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are taking. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is essential to avoid pregnancy.

Hertab 250 mg Tablet 30N should be taken exactly as prescribed by your doctor. Take Hertab 250 mg Tablet 30N at least 1 hour before or after taking the food. Swallow the tablet and do not crush, open, or dissolve them. It is important to follow your doctor's instructions for taking Hertab 250 mg to continue taking the medication as prescribed even if you feel well. Do not stop taking Hertab 250 mg Tablet 30N or change your dosage without consulting your doctor.

Uses of Hertab 250 mg Tablet 30N

• Breast Cancer

Benefits of Hertab 250 mg Tablet 30N

Hertab 250 mg Tablet 30N helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Hertab 250 mg Tablet 30N kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

Side Effects of Hertab 250 mg Tablet 30N

Hertab 250 mg Tablet 30N adverse effects can vary from person to person depending on the severity as well as the immunity. Depending on that, you can have mild, moderate, or severe effects.

Most Common Side Effects of Hertab 250 mg Tablet 30N

• Vomiting
• Nausea
• Back and Joint Pain
• Headache
• Hair Loss
• Skin dryness and itching
• Breathlessness
• Weakness
• Mouth Ulcers
• Nose Bleeding
• Stomach Pain
• Hot Flushes

Common Side Effects of Hertab 250 mg Tablet 30N

• Skin Rashes
• Allergic Reactions
• Heart Problems
• Diarrhoea
• Insomnia

How to Use Hertab 250 mg Tablet 30N?

Hertab 250 mg Tablet 30N should be taken exactly as prescribed by your doctor or take least 1 hour before or after taking the food. Swallow the tablet and do not crush, open, or dissolve them.

How Hertab 250 mg Tablet 30N Works?

Hertab 250 mg Tablet 30N belongs to a class of drugs called tyrosine kinase inhibitors. It is primarily used in the treatment of certain types of breast cancer that overexpress a protein called human epidermal growth factor receptor 2 (HER2).HER2 is a protein that plays a role in the growth and division of cells. By blocking the activity of HER2 and EGFR, Hertab 250 mg helps to interrupt the signalling pathways that promote the growth and survival of cancer cells. This can lead to a reduction in the growth of the tumour and, in some cases, shrinkage of the tumour.

Safety Advices Hertab 250 mg Tablet 30N

Alcohol

Unsafe

Driving

Unsafe

Liver

Use with Caution

Kidney

Use with Caution

Pregnancy

Unsafe

Breastfeeding

Unsafe

References

1. Lapatinib, Drugs.Com, Avaliable Form

2. Tykerb (Lapatinib) Tablets, GlaxoSmithKline, Product Leaflet

3. Lapatinib, Medline Plus. Com, Avaliable Form

4. Lapatinib (as Ditosilate Monohydrate), Novartis Pharmaceuticals Australia Pty Limited, Product Leaflet